Kelly Benchmark Indexes

Kelly ETFs offers investors the opportunity to capture highly liquid, pure-play exposure to the best-in-class companies identified in each emerging theme or sector. Funds offered include the Kelly Hotel & Lodging Sector ETF (NYSE Arca: HOTL), Kelly Residential & Apartment Real Estate ETF (NYSE Arca: RESI), and the Kelly CRISPR & Gene Editing Technology ETF (Nasdaq: XDNA).

Company Schedule

Thursday, November 10, 2022 - 2:40 pm to 3:10 pm EST The CIA, CRISPR, and Cholesterol: The Latest Developments in Biotech by Kevin Kelly - CEO, Kelly ETFs Focus: ETFs

CRISPR technology has had two watershed moments this summer, indicating that it is about change healthcare as we know it. Since then, there have been investments into CRISPR companies from the CIA and developments in the heart disease space. Learn about the upcoming catalysts for publicly traded gene-editing companies. At its core, CRISPR is a pair of biological scissors that cuts and replaces genes in living organisms' cells.

Friday, November 11, 2022 - 11:55 am to 12:40 pm EST Cutting Edge ETFs Kevin Kelly - CEO, Kelly ETFs Focus: ETFs

Join moderator Jeffrey Hirsch with panelists David Mazza and Kevin Kelly for a drill down into the newest levereged and inverse ETFs from Direxion and the latest, hottest trends in biotech ETF investing from Kelly ETFs.


For questions please contact our Client Relations Team at 800-970-4355 or 941-955-0323.

Social Updates

Follow us on social media to stay in the loop as more great speakers are added to the schedule!